← Back to Search

Diagnostic Test

Glucose Tolerance Testing for Diabetes Risk in Children

N/A
Recruiting
Led By Sonia Caprio, MD
Research Sponsored by Yale University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Ages 7-21
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up completed at baseline measurement
Awards & highlights

Study Summary

This trial looks at how common diabetes is in children who are either skinny with a family history of diabetes, or overweight/obese with or without a family history of diabetes.

Who is the study for?
This trial is for children aged 7-21 who either have a family history of type 2 diabetes or are overweight/obese. It's not open to kids on certain meds that affect blood sugar, those with other hormonal disorders, or those treated with steroids, antirejection drugs, or chemotherapy.Check my eligibility
What is being tested?
The study aims to find out how common carbohydrate intolerance is in lean and overweight/obese kids by using an Oral Glucose Tolerance Test (OGTT). This test involves drinking a sugary solution and measuring blood sugar levels at intervals.See study design
What are the potential side effects?
An OGTT can cause side effects like feeling sick, bloated, lightheadedness due to fasting before the test and the sudden intake of glucose. Some may also experience low blood sugar after the test.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 7 and 21 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline measurements
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline measurements for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Glucose Tolerance
Secondary outcome measures
Insulin resistance
Other outcome measures
Gene Expression

Trial Design

2Treatment groups
Experimental Treatment
Group I: Obese/overweight chldren/adolescentsExperimental Treatment1 Intervention
Obese or overweight children and adolescents between ages 7-21 that are at risk for developing type 2 diabetes will undergo an Oral Glucose Tolerance test (OGTT) to asses glucose status.
Group II: Lean children/adolescentsExperimental Treatment1 Intervention
Lean children/adolescents between the ages of 7-21. This cohort should have family members that have type 2 diabetes or was the result of a gestational diabetes pregnancy. They will undergo an Oral Glucose Tolerance Test to assess glucose status.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Oral Glucose tolerance test
2015
N/A
~20

Find a Location

Who is running the clinical trial?

Yale UniversityLead Sponsor
1,864 Previous Clinical Trials
2,740,265 Total Patients Enrolled
60 Trials studying Obesity
246,163 Patients Enrolled for Obesity
National Institutes of Health (NIH)NIH
2,720 Previous Clinical Trials
7,492,446 Total Patients Enrolled
104 Trials studying Obesity
24,148 Patients Enrolled for Obesity
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
1,978 Previous Clinical Trials
2,678,353 Total Patients Enrolled
105 Trials studying Obesity
100,323 Patients Enrolled for Obesity

Media Library

Oral Glucose Tolerance Test (Diagnostic Test) Clinical Trial Eligibility Overview. Trial Name: NCT01967849 — N/A
Obesity Research Study Groups: Obese/overweight chldren/adolescents, Lean children/adolescents
Obesity Clinical Trial 2023: Oral Glucose Tolerance Test Highlights & Side Effects. Trial Name: NCT01967849 — N/A
Oral Glucose Tolerance Test (Diagnostic Test) 2023 Treatment Timeline for Medical Study. Trial Name: NCT01967849 — N/A
~90 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top